Multimodal EEG and NIRS-based BCI With Assistive Soft Robotics for Stroke (MBCI-SR) (MBCI-SR)

December 7, 2022 updated by: Chloe Chung Lau Ha, Tan Tock Seng Hospital

Multimodal EEG and NIRS-based BCI With Assistive Soft Robotics for Stroke

One-third of patients who had stroke suffered persistent disabilities, and upper limb (UL) motor impairment is one of the main disabilities. Recent clinical studies had been conducted using non-invasive EEG-based BCI via motor imagery, for post-stroke rehabilitation, yielded motor improvement of 7.2 on the Fugl-Meyer Motor Assessment (FMA-UE)score in chronic stroke patients that is significantly better than standard care. However, all the stroke patients underwent the same "one-size-fits-all" treatment option involving all six different activities of daily living (ADL)-oriented tasks regardless of their impairment or ability.

Investigators hypothesize that precision personalized stroke rehabilitation intervention that is tailored to the patient hold more promise than a "one-size-fits-all" stroke rehabilitation strategy.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

  1. To address the "one-size-fits-all" stroke rehabilitation strategy, RRIS will develop an Ability data-driven personalized stroke rehabilitation based on the stroke patient's UL impairment and motor ability, by first matching 6 UL tasks in RRIS Ability Database with the 6 ADL tasks of the BCI-SR Intervention via similarity indices. A personalized subset of ADL tasks treatment options is then generated by a data-driven recommendation based on the patient's ability, movement pattern of the treatment option and the normative data from the RRIS Ability Database. A multi-modal BCI is proposed to perform EEG subject-specific calibration using Near-infrared spectroscopy, NIRS to ensure motor imagery compliance.
  2. stroke subjects with UL impairments (score 11-45 on the FMA-UE) will be recruited to undergo the UL tasks assessment at RRIS. They will then undergo the personalized stroke rehabilitation using the Multimodal EEG and NIRS-based BCI with Soft Robotic therapy for 1.5 hour over 6 weeks, 3 times a week. The effectiveness of the personalized stroke rehabilitation can then be retrospectively compared to the use of "one-size-fits-all" ADL tasks in the previous clinical trial.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Singapore, Singapore, 569766
        • Recruiting
        • Tan Tock Seng Hospital Rehabilitation Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • first ever stroke prior to clinical trial
  • Fugl-Meyer Assessment scale of upper extremity impairment of 11-45 out of a maximum score of 66
  • ability to give own consent
  • ability to pay attention and maintain supported sitting for 1.5 hours continuously
  • able to comprehend and follow commands
  • fulfils BCI resting brain states on initial screening
  • unilateral upper limb impairment

Exclusion Criteria:

  • recurrent stroke
  • inability to follow command and sit upright for 1.5 hours
  • hemi-spatial neglect
  • spasticity assessed by Modified Ashworth Scale more than 2/4
  • History of Epilepsy
  • Fixed contracture / deformity of finger joints
  • upper limb pain impeding movements with visual analogy scale > 4/10
  • Severe aphasia or cognitive impairment despite visual aids
  • other conditions ensuing upper limb weakness
  • poor skin conditions
  • skull defect that might affect EEG or NIRS reading
  • allergy to electrodes or adhesive gel
  • significant vision and hearing impairment affecting participation
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MBCI-SR
BCI based robotic rehabilitation works by detecting the motor intent of the user from Electroencephalogram signals to drive rehabilitation assisted by the soft robotics gloves.
Participants will be asked to wear and EEG+NIRS cap and a soft robotic glove on their stroke-impaired hand. The participant will be instructed to ask to imagine to picture moving the stroke-imparied hand in the mind. The brain signal (EEG and NIRS data) will be recorded as a reference. When the participant pictures this move again, upon detection of such imagined move by MBCI-SR system, the glove will be activated and assists the participants to perform a specific upper limb task based on individual ability. There are six different activities of daily living (ADL)-oriented tasks enacted through a virtual arm and virtual objects, which formed the visual feedback for the participants. These tasks include scanning goods, moving an object upward to a cabinet, using two hands to move a towel, pouring of water into a cup, eating action and fine motor movement of picking up a small block using two fingers. Training intensity is 1.5 hours for 3 times a week for 6 weeks, a total of 18 sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer score of upper limb
Time Frame: Baseline
a measure for upper extremity, movement coordination and reflex action.
Baseline
Fugl-Meyer score of upper limb
Time Frame: at week 4 (mid point)
a measure for upper extremity, movement coordination and reflex action.
at week 4 (mid point)
Fugl-Meyer score of upper limb
Time Frame: at week 6 (completion of intervention)
a measure for upper extremity, movement coordination and reflex action.
at week 6 (completion of intervention)
Fugl-Meyer score of upper limb
Time Frame: at week 12 (at 3 month post intervention)
a measure for upper extremity, movement coordination and reflex action.
at week 12 (at 3 month post intervention)
Fugl-Meyer score of upper limb
Time Frame: at week 24 (at 6 month post intervention)
a measure for upper extremity, movement coordination and reflex action.
at week 24 (at 6 month post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test
Time Frame: Baseline
A measure for upper extremity functioning, such as dexterity and motor coordination, the key components in performing ADLs
Baseline
Action Research Arm Test
Time Frame: at week 12 (at 3 months post intervention)
A measure for upper extremity functioning, such as dexterity and motor coordination, the key components in performing ADLs
at week 12 (at 3 months post intervention)
Action Research Arm Test
Time Frame: at week 24 ( at 6 months post intervention)
A measure for upper extremity functioning, such as dexterity and motor coordination, the key components in performing ADLs
at week 24 ( at 6 months post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chloe Lauha Chung, PhD, Tan Tock Seng Hospital
  • Principal Investigator: Kai Keng Ang, Institute for Infocomm Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2022

Primary Completion (Anticipated)

September 14, 2023

Study Completion (Anticipated)

December 14, 2023

Study Registration Dates

First Submitted

November 15, 2022

First Submitted That Met QC Criteria

December 7, 2022

First Posted (Estimate)

December 8, 2022

Study Record Updates

Last Update Posted (Estimate)

December 8, 2022

Last Update Submitted That Met QC Criteria

December 7, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Share the study protocol, clinical study report and results

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on MBCI-SR

3
Subscribe